Literature DB >> 27656386

Core Decompression Augmented With Autologous Bone Marrow Aspiration Concentrate for Early Avascular Necrosis of the Femoral Head.

Lucas Arbeloa-Gutierrez1, Chase S Dean2, Jorge Chahla2, Cecilia Pascual-Garrido3.   

Abstract

Lack of necessary perfusion to the femoral head can lead to necrosis of the underlying bone (avascular necrosis) and result in femoral and acetabular surface changes in advanced stages. Numerous treatments have been reported in the literature, including nonoperative and surgical procedures. In addition to the standard core decompression, we describe the use of bone marrow aspirate to stimulate a healing response and bone grafting, allowing for immediate weight bearing postoperatively. The purpose of this article was to describe our method of core decompression augmented with bone marrow aspirate concentrate and bone grafting for the treatment of early avascular necrosis of the femoral head.

Entities:  

Year:  2016        PMID: 27656386      PMCID: PMC5021452          DOI: 10.1016/j.eats.2016.02.009

Source DB:  PubMed          Journal:  Arthrosc Tech        ISSN: 2212-6287


  20 in total

1.  Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells.

Authors:  Dewei Zhao; Daping Cui; Benjie Wang; Fengde Tian; Lin Guo; Lei Yang; Baoyi Liu; Xiaobing Yu
Journal:  Bone       Date:  2011-11-07       Impact factor: 4.398

2.  A current review of core decompression in the treatment of osteonecrosis of the femoral head.

Authors:  Todd P Pierce; Julio J Jauregui; Randa K Elmallah; Carlos J Lavernia; Michael A Mont; James Nace
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

3.  Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment.

Authors:  R P Ficat
Journal:  J Bone Joint Surg Br       Date:  1985-01

Review 4.  Current concepts on osteonecrosis of the femoral head.

Authors:  Joaquin Moya-Angeler; Arianna L Gianakos; Jordan C Villa; Amelia Ni; Joseph M Lane
Journal:  World J Orthop       Date:  2015-09-18

5.  Stage-related results in treatment of hip osteonecrosis with core-decompression and autologous mesenchymal stem cells.

Authors:  Pietro Persiani; Claudia De Cristo; Jole Graci; Giovanni Noia; Michele Gurzì; Ciro Villani
Journal:  Acta Orthop Belg       Date:  2015-09       Impact factor: 0.500

Review 6.  Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. Surgical technique.

Authors:  Valérie Gangji; Jean-Philippe Hauzeur
Journal:  J Bone Joint Surg Am       Date:  2005-03       Impact factor: 5.284

7.  Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein.

Authors:  Jay R Lieberman; Augustine Conduah; Marshall R Urist
Journal:  Clin Orthop Relat Res       Date:  2004-12       Impact factor: 4.176

8.  The natural history of the silent hip in bilateral atraumatic osteonecrosis.

Authors:  J K Bradway; B F Morrey
Journal:  J Arthroplasty       Date:  1993-08       Impact factor: 4.757

Review 9.  Osteonecrosis of the femoral head: evaluation and treatment.

Authors:  Charalampos G Zalavras; Jay R Lieberman
Journal:  J Am Acad Orthop Surg       Date:  2014-07       Impact factor: 3.020

10.  Use of concentrated bone marrow aspirate and platelet rich plasma during minimally invasive decompression of the femoral head in the treatment of osteonecrosis.

Authors:  John R Martin; Matthew T Houdek; Rafael J Sierra
Journal:  Croat Med J       Date:  2013-06       Impact factor: 1.351

View more
  11 in total

1.  Bone Marrow Aspirate Concentrate Harvesting and Processing Technique.

Authors:  Jorge Chahla; Sandeep Mannava; Mark E Cinque; Andrew G Geeslin; David Codina; Robert F LaPrade
Journal:  Arthrosc Tech       Date:  2017-04-10

2.  Core decompression and bone marrow aspirate concentrate injection for Avascular Necrosis (AVN) of the femoral head: A scoping review.

Authors:  Nishant Pawar; Abhishek Vaish; Raju Vaishya
Journal:  J Clin Orthop Trauma       Date:  2021-11-11

3.  Sesamoid Avascular Necrosis and Stress Fracture Treated with Core Decompression and Biologic Augmentation.

Authors:  Victoria A Scala; Christian K Kikuchi
Journal:  Hawaii J Health Soc Welf       Date:  2022-03

4.  Patient and Disease Related Risk Factors Associated With Return to Sport Rates After AVN Treatment.

Authors:  Patrick England; Julien Y Aoyama; Divya Talwar; Lawrence Wells
Journal:  Iowa Orthop J       Date:  2022-06

5.  Comparison of the outcome of different bone grafts combined with modified core decompression for the treatment of ARCO II stage femoral head necrosis.

Authors:  Junming Wan; Yanqing Hu; Jiachun Li; Yuqing Zeng; Haiyong Ren
Journal:  Int Orthop       Date:  2022-05-10       Impact factor: 3.479

6.  Intraosseous Bioplasty for a Subchondral Cyst in the Lateral Condyle of Femur.

Authors:  Anish G R Potty; Ashim Gupta; Hugo C Rodriguez; Ian W Stone; Nicola Maffulli
Journal:  J Clin Med       Date:  2020-05-06       Impact factor: 4.241

7.  Arthroscopic Bone Marrow Aspirate Concentrate Harvesting From the Intercondylar Notch of the Knee.

Authors:  Gun Min Youn; Brittany M Woodall; Nicholas Elena; Edward C Shin; Neil Pathare; Patrick J McGahan; James L Chen
Journal:  Arthrosc Tech       Date:  2018-10-22

8.  Intraosseous Bioplasty for a Chondral Cyst in the Lateral Tibial Plateau.

Authors:  Nicholas Elena; Brittany M Woodall; Katie Lee; Patrick J McGahan; Neil P Pathare; Edward C Shin; James L Chen
Journal:  Arthrosc Tech       Date:  2018-10-15

Review 9.  What are the outcomes of core decompression without augmentation in patients with nontraumatic osteonecrosis of the femoral head?

Authors:  Octavian Andronic; Ori Weiss; Haitham Shoman; Philipp Kriechling; Vikas Khanduja
Journal:  Int Orthop       Date:  2020-09-04       Impact factor: 3.075

10.  What are the outcomes of core decompression in patients with avascular necrosis? Protocol for a systematic review.

Authors:  Octavian Andronic; Haitham Shoman; Ori Weiss; Vikas Khanduja
Journal:  F1000Res       Date:  2020-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.